Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting

American Journal of Cardiology

Volumn 78, Issue 9, 1996, Pages 1042-1044

  Goods, Christopher M ^a   Al Shaibi, Khaled F ^a   Liu, Ming W ^a   Yadav, Jay S ^a   Mathur, Atul ^a   Jain, Suresh P ^a   Dean, Larry S ^a   Iyer, Sriram S ^a   Parks, J Michael ^a   Roubin, Gary S ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

AGED; ARTICLE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG COMBINATION; FEMALE; HUMAN; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; STENT; THROMBOSIS; TREATMENT OUTCOME;

AGED; ASPIRIN; CORONARY DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; STENTS; THROMBOSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 10644231972     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00532-2     Document Type: Article

References (10)

1. Colombo A, Hall P, Nakamura S, Almagor Y, Maiello L, Martini G, Gaglione A, Goldberg SL, Tobis J, Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-1688.
2. Goods CM, Al-Shaibi KF, Yadav SS, Liu MW, Negus BH, Iyer SS, Dean LS, Jain SP, Baxley WA, Parks JM, Sutor RJ, Roubin GS. Utilization of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound. Circulation; in press.
3. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J, Turpie AGG. The Canadian American ticlopidine study in thromboembolic stroke. Lancet 1989;1215-1220.
4. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, Kamm B, for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high risk patients. N Engl J Med 1989;321:501-507.
5. Ho DSW, Liu MW, Iyer S, Parks JM, Roubin GS. Sizing the Gianturco-Roubin coronary flexible coil stent. Cathet Cardiovasc Diagn 1994;32:242-248.
6. Morice MC, Amor M, Benveniste E, Bunouf P, Cribler A, Labrunie P, Masquet C, Petiteau. Coronary stenting without coumadin phase II, III, IV, V. Predictors of major complications (abstr). Circulation 1995;92(suppl I):I-795.
7. Nath FC, Muller DWM, Ellis SG, Rosenschein U, Chapekis A, Quain L, Zimmerman C, Topol EJ. Thrombosis of a flexible coil stent: frequency, predictors and clinical outcome. J Am Coll Cardiol 1993;21:622-627.
8. Sutton JM, Ellis SG, Roubin GS, Pinkerton CA, King SB, Raizner AE, Holmes DR, Kereiakes DJ, Topol EJ. Major clinical events after coronary stenting: the multicenter registry of acute and elective Gianturco-Roubin stent placement. Circulation 1994;89:1126-1137.
9. Herrmann HC, Buchbinder M, Clemen MW, Fischman D, Goldberg S, Leon MB, Schatz RA, Tierstein P, Walker CM, Hirshfeld JW. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992;86:812-819.
10. Hall P, Nakamura S, Maiello L, Itoh A, Blengino S, Martini G, Ferraro M, Colombo A. A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation 1996;93:215-222.